Indiana University Hospital
Indianapolis, Indiana, 46202, United States
Location status: Recruiting
NCT Number: NCT04434781
Gastric Per-Oral Endoscopic Myotomy (G-POEM) is a procedure for the Treatment of Gastroparesis.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Indianapolis, Indiana, 46202, United States
Location status: Recruiting
Gastroparesis is a disease of the stomach where there is significant delay in gastric emptying of contents to the intestines. This disease results in a multitude of symptoms including nausea, vomiting, weight loss, and malnutrition.
Current treatments for gastroparesis include dietary changes, oral medications (prokinetic agents to enhance gastric motility, acid reducers, anti-emetics to reduce nausea and vomiting), gastric stimulators and rarely surgery.
G-POEM (Gastric Per-Oral Endoscopic Myotomy-creating a cut in the muscle that controls gastric emptying), an incision-less (no cutting of the surface of the body) endoscopic procedure, is increasingly being performed to assist in the management of certain groups of patients with gastroparesis.
This data will be used for research purposes only to determine the clinical impact of endoscopic treatments on gastroparesis. The physicians will also be able to better understand the patient's condition and disease process that may lead to improved standard of care and improved patient management.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 60 months span: baseline and assess change at 1 month, 3 month, 6 month, 12 month, 24 month, 36 month, 48 month & 60 months
The Gastroparesis Cardinal Symptom Index (GCSI) is used for assessing severity of symptoms associated with gastroparesis. Patients are to score each of the 9 symptom criteria on 0 (None) to 5 (Very Severe) Likert Scale. The higher the score the more symptomatic from gastroparesis the patient is.
Nausea or Vomiting (score 0-5 for each of the following 3 criteria)
Time frame: 60 months span: baseline and assess change at 1,3,6,12,24, 36,48 & 60 months
Change in PAGI-Sym score: The PAGI-SYM is composed of 20 items and 6 subscales: heartburn/regurgitation (7 items), nausea/vomiting (3 items), postprandial fullness/early satiety (4 items), bloating (2 items), upper abdominal pain (2 items), and lower abdominal pain (2 items). Subscale scores are calculated by averaging across items comprising the subscale; scores vary from 0 (none or absent) to 5 (very severe)
Time frame: baseline and assess change at 1,3,6,12,24,36,48 & 60 months
Change in health belief questionnaire (SF-36) score: Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability and the higher scores indicate better health
Time frame: baseline; and assess change at 6, and 24 months
we will track change in GES at 6 months and 24 months post G-POEM and compare to baseline. Normal GES should have under 5% at 4 hours
Contact information is provided by the study sponsor or research team.
Jacque Peterman
CONTACT
Mohammad Al-Haddad, MD
CONTACT
Indiana University
Other
Gastric Per-Oral Endoscopic Myotomy (G-POEM) for the Treatment of Gastroparesis: A Database Repository
Acronym: G-POEM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07717541
Anxiety, Anxiety Disorders
Columbus, Ohio, United States
View Trial DetailsNCT04506593
Chronic Intestinal Pseudo-obstruction, Colonic Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT02165059
Deglutition Disorders, Digestive System Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT06854120
Digestive System Diseases, Functional Dyspepsia
Philadelphia, Pennsylvania, United States
View Trial Details